MaxPro Medical
Melbourne, as the healthcare and biotechnology hub of Australia, is witnessing a paradigm shift in chronic disease management. Continuous Glucose Monitoring (CGM) technology has transitioned from a niche clinical tool to a mainstream necessity for diabetes care. As a premier CGM Factory and Exporter, MaxPro Medical is at the forefront of this revolution, providing high-accuracy sensor technology that meets the stringent demands of the Victorian healthcare landscape.
In Melbourne and the broader Victoria region, the prevalence of Type 1 and Type 2 diabetes continues to rise, placing significant pressure on the public health system. The Australian governmentās National Diabetes Services Scheme (NDSS) has been a catalyst for CGM adoption. However, there remains a substantial demand for cost-effective, high-precision alternatives for those not covered by full subsidies or for private clinical research centers in the Parkville Biomedical Precinct.
Our export strategies for the Melbourne market focus on interoperabilityāensuring our sensors communicate seamlessly with local healthcare apps and clinic management software used by endocrinologists at the Royal Melbourne Hospital and Alfred Health.
Sensor Lifespan
MARD Accuracy
Global Compliance
Data Monitoring
Globally, the CGM market is projected to reach over $12 billion by 2028. The industry is moving away from traditional "finger-stick" glucose meters toward wearable biosensors that measure interstitial fluid glucose levels in real-time. As a leading manufacturer, MaxPro Medical integrates Electro-chemical biosensor technology with low-power Bluetooth (BLE 5.0) to provide a stable, long-term monitoring solution.
Our manufacturing facility in Shenzhen serves as a global hub, utilizing automated precision assembly lines to ensure that every sensor unit exported to Melbourne meets the "Quality First" principle. With the global supply chain facing volatility, our vertical integrationāfrom raw material sourcing to final packingāguarantees a stable supply for Australian distributors.
The future of CGM isn't just about showing a number; itās about Information Gain. Our R&D department is currently focusing on three primary technical pillars:
Our CGM systems are designed for diverse Melbourne-specific scenarios:
Founded in 2009, Shenzhen MaxPro Medical Co., Ltd. is a leading manufacturer specializing in advanced medical devices and chronic disease monitoring solutions. With a strong commitment to innovation, quality, and customer satisfaction, we provide reliable healthcare technologies to over 500 healthcare institutions and distributors worldwide.
Our company operates a modern 20,000 sq ft manufacturing facility equipped with advanced production and testing systems. Certified under ISO 13485 quality management standards, all of our products comply with international medical regulations, with key products receiving FDA 510(k) clearance and CE certification.
With years of experience in the medical device industry, Shenzhen MaxPro Medical Co., Ltd. has built long-term partnerships with healthcare providers, distributors, and medical institutions around the world. Our products are widely recognized for their stable performance, reliable quality, and user-friendly design.
Continuous Glucose Monitoring Blood Glucose Monitor Melbourne Series
CGM System Sensor & Transmitter - Melbourne Clinical Grade
High Quality Melbourne CGM System Non Invasive Tech
Melbourne Universal Compatibility CGM ISO13485
Melbourne Industry-Leading Accuracy CGM Sensor
15 Day Melbourne Ultra-Low Power CGM System
Melbourne 15 Days X24 Hours Precision CGM
CGM Melbourne Offline Data Storage Up to 15 Days